NASDAQ: ARTV
Artiva Biotherapeutics Inc Earnings Dates, Reports, Calls

Artiva Biotherapeutics earnings were -$75.1M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest ARTV earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$21.3M, up 4.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ARTV reported annual earnings of -$65.4M, with 127.6% growth. The next ARTV earnings date is Aug 28, 2025.

ARTV earnings history

Current Revenue
$0.0
Current Earnings
-$75.1M
Current Profit Margin
0%

ARTV Return on Equity

Current Company
-42.6%
Current Industry
-9%
Current Market
27%
ARTV's Return on Equity (-42.6%)... subscribe to Premium to read more.
High Return on Equity Performance

ARTV undefined

Current Company
-37.8%
Current Industry
0.3%
ARTV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ARTV announces earnings.

ARTV undefined

Current Company
-47.37%
Current Industry
8.2%

ARTV vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ARTV-$72.62M-$75.13MN/A-$1.27
INMB-$55.51M-$55.51MN/A-$2.48
RPTX-$121.75M-$127.89MN/A-$3.02
COEP-$8.95M-$10.37MN/A-$4.73
INKT-$11.06M-$11.27MN/A-$2.92

ARTV earnings dates

Next earnings date
Aug 28, 2025

Artiva Biotherapeutics Earnings Reports & History FAQ

What were Artiva Biotherapeutics's earnings last quarter?

On ARTV's earnings call on Invalid Date, Artiva Biotherapeutics (NASDAQ: ARTV) reported Q2 2025 earnings per share (EPS) of -$0.87, up 96.05% year over year. Total ARTV earnings for the quarter were -$21.25 million. In the same quarter last year, Artiva Biotherapeutics's earnings per share (EPS) was -$22.00.

If you're new to stock investing, here's how to buy Artiva Biotherapeutics stock.

When does Artiva Biotherapeutics report earnings?

The next ARTV earnings call is Invalid Date. Add ARTV to your watchlist to be reminded of Artiva Biotherapeutics's next earnings date.

Is Artiva Biotherapeutics profitable or losing money?

As of the last Artiva Biotherapeutics earnings report, Artiva Biotherapeutics is currently losing money. Artiva Biotherapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$75.13 million, a 131% increase year over year.

What was ARTV's earnings growth in the past year?

As of Artiva Biotherapeutics's earnings date in Invalid Date, Artiva Biotherapeutics's earnings has grown year over year. ARTV earnings in the past year totalled -$75.13 million.

What are Artiva Biotherapeutics's earnings expectations?

The current EPS estimate for Artiva Biotherapeutics's earnings report in Invalid Date is -$0.77.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.